Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study

Clinical trial data and real-world evidence suggest that the AS04-adjuvanted vaccine targeting human papillomavirus types 16 and 18 (AS04-HPV-16/18) vaccine provides nearly 90% protection against cervical intraepithelial neoplasia grade 3 or higher irrespective of type, among women vaccinated before...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Infect Dis
Главные авторы: Tota, Joseph E, Struyf, Frank, Hildesheim, Allan, Gonzalez, Paula, Ryser, Martin, Herrero, Rolando, Schussler, John, Karkada, Naveen, Rodriguez, Ana Cecilia, Folschweiller, Nicolas, Porras, Carolina, Schiffman, Mark, Schiller, John T, Quint, Wim, Kreimer, Aimée R, Lehtinen, Matti, Wheeler, Cosette M, Sampson, Joshua N
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Major Articles and Brief Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248553/
https://ncbi.nlm.nih.gov/pubmed/32887990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa561
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы